Could cardiorenal benefits of sodium-glucose co-transporter 2 inhibitors be extended to type 1 diabetes mellitus? Popovic DS, Stoian AP, Papanas N. J Diabetes Complications 2022;36:108338.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Popovic DS, Stoian AP, Papanas N. Could cardiorenal benefits of sodium-glucose co-transporter 2 inhibitors be extended to type 1 diabetes mellitus? J Diabetes Complications 2022;36:108338.
PMID: 36240667